This paper looked at FTO overexpression in head and neck cancer (OSCC) and found it was involved in some patients cancers and that inhibiting FTO was a target [1]. There are other papers identifying FTO in other SCC’s [2, 3].
1. Pilžys, T., Marcinkowski, M., Kukwa, W., Garbicz, D., Dylewska, M., Ferenc, K., et al. (2019). ALKBH overexpression in head and neck cancer: potential target for novel anticancer therapy. Nature Publishing Group, 9(1), 13249. http://doi.org/10.1038/s41598-019-49550-x
2. Zhou, S., Bai, Z.-L., Xia, D., Zhao, Z.-J., Zhao, R., Wang, Y.-Y., & Zhe, H. (2018). FTO regulates the chemo-radiotherapy resistance of cervical squamous cell carcinoma (CSCC) by targeting β-catenin through mRNA demethylation. Molecular Carcinogenesis, 57(5), 590–597. http://doi.org/10.1002/mc.22782
3. Liu, J., Ren, D., Du, Z., Wang, H., Zhang, H., & Jin, Y. (2018). m 6 A demethylase FTO facilitates tumor progression in lung squamous cell carcinoma by regulating MZF1 expression. Biochemical and Biophysical Research Communications, 502(4), 456–464. http://doi.org/10.1016/j.bbrc.2018.05.175
- Forums
- ASX - By Stock
- RAC
- Medical / Clinical Discussions
Medical / Clinical Discussions, page-365
-
-
- There are more pages in this discussion • 134 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.83 |
Change
0.020(1.11%) |
Mkt cap ! $310.7M |
Open | High | Low | Value | Volume |
$1.81 | $1.83 | $1.79 | $142.0K | 78.77K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 500 | $1.81 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.83 | 641 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 500 | 1.810 |
3 | 7009 | 1.790 |
1 | 450 | 1.780 |
2 | 16392 | 1.770 |
2 | 1018 | 1.765 |
Price($) | Vol. | No. |
---|---|---|
1.830 | 558 | 1 |
1.840 | 4000 | 2 |
1.845 | 2746 | 1 |
1.860 | 1000 | 1 |
1.870 | 1200 | 1 |
Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online